Omid Yeganeh | Immunology and Microbiology | Best Scholar Award

Published on by Academic Awards

Omid Yeganeh | Immunology and Microbiology | Best Scholar Award

Dr Omid Yeganeh, Islamic Azad University, Iran

Dr. Omid Yeganeh is a microbiologist with a Ph.D. in Microbiology from the Islamic Azad University, Tehran, Iran. He also holds an M.Sc. in Microbiology and a B.Sc. in Cellular and Molecular Biology. As a researcher at the Monoclonal Antibody Research Center, Avicenna Research Institute, he specializes in producing monoclonal antibodies against various molecules, including PSA, prolactin, ferritin, and sperm surface antigens. Dr. Yeganeh serves as a technical editor and associate editor for several journals, contributing to the advancement of microbiological research. His work has significantly impacted the field of immunology and antibody development. 🔬🧬💉

Publication profile

google scholar

Education

Dr. Omid Yeganeh holds an impressive academic background, earning a Ph.D. in Microbiology from the Department of Microbiology at the Islamic Azad University, Tehran, Iran. His M.Sc. in Microbiology and B.Sc. in Cellular and Molecular Biology with a focus on Microbiology further enhance his foundational knowledge in the field. As a member of the Monoclonal Antibody Research Center at the Avicenna Research Institute, he is well-versed in cutting-edge research methodologies.

Research Experience

Dr. Yeganeh’s extensive experience as a researcher at the Monoclonal Antibody Research Center showcases his commitment to advancing the field of microbiology and immunology. His role as a technical editor and associate editor for scientific journals highlights his expertise and active participation in academic discourse. His hands-on research experience equips him with a practical understanding of the latest methodologies in microbiology.

Research Activities

His work focuses on the production of monoclonal antibodies against various clinically significant molecules, including PSA, prolactin, and sperm surface antigens. He has successfully produced monoclonal antibodies against over 100 different peptides, showcasing his technical expertise in hybridoma techniques and cell culture. This innovative research has the potential to contribute significantly to diagnostic and therapeutic applications in medicine.

Congress Participation

Dr. Yeganeh actively participates in international congresses, such as the 15th Virtual International Congress of Immunology & Allergy and the ICIA 2023, where he presents his research findings. His engagement in these forums not only broadens his professional network but also enhances the visibility of his research contributions on a global scale.

Research focus

Dr. Omid Yeganeh is a prominent researcher with a focus on medical biotechnology, particularly in immunology and microbiology. His work includes the production and characterization of monoclonal antibodies against various human proteins and pathogens, highlighting his expertise in antibody development for diagnostic and therapeutic applications. He has also investigated infectious diseases, including the emergence of antibiotic-resistant bacteria, contributing to the understanding of microbial drug resistance. His research significantly impacts both clinical diagnostics and therapeutic strategies. 🧬🔬📊

Publication top notes

Intra-and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction …

The Challenge of Global Emergence of Novel Colistin-Resistant Escherichia coli ST131

Immunohistochemical characterization of novel murine monoclonal antibodies against human placenta‐specific 1

A survey on the prevalence of Chlamydia trachomatis and Mycoplasma genitalium infections in symptomatic and asymptomatic men referring to urology clinic of Labbafinejad …

Production and characterization of a murine monoclonal antibody against human ferritin

Skull base aneurysmal bone cyst presented with foramen jugular syndrome and multi-osseous involvement

Fibro-osseous lesions of the skull base in the pediatric population

Production and characterization of monoclonal antibodies against human prostate specific antigen

Conclusion

Dr. Omid Yeganeh’s academic credentials, research experience, and extensive publication record make him a highly suitable candidate for the Best Researcher Award. His innovative research in monoclonal antibody production and his commitment to advancing scientific knowledge in microbiology not only demonstrate his capabilities as a researcher but also indicate his potential for future contributions to the field.

 

Keun Hyung Park | Clinical Research | Best Researcher Award

Published on by Academic Awards

Dr. Keun Hyung Park | Clinical Research | Best Researcher Award

Dr. Keun Hyung Park, Sunjin Clinical Research Center (SCRC), Sunjin BeautyScience Co., Ltd., South Korea

Dr. Keun Hyung Park is an accomplished expert in genetic engineering and immunology, with a PhD from Kyung Hee University (2014). He currently serves as the Head of Sunjin Clinical Research Center and is an advisory committee member at Korea Bio Research Center. Dr. Park has published extensively on skin science, wound healing, and inflammation, contributing to top journals like J Immunol and Skin Research & Technology. He is also a recognized voice in the cosmetics industry through his insightful columns on K-beauty trends. 🧬💼💡 His expertise spans molecular biology, clinical research, and dermatological studies.

Publication profile

Scopus

Education 🎓

Dr. Keun Hyung Park holds advanced degrees in Genetic Engineering with a focus on Immunology from Kyung Hee University. He earned his Master’s degree in 2008, gaining a strong foundation in molecular biology and immunology. Continuing his academic journey, he completed his PhD in 2014, further specializing in immunology-related genetic engineering. His extensive education has equipped him with the expertise to contribute significantly to the fields of molecular biology, clinical research, and dermatology, positioning him as a leader in both academic and industry settings. 🧬📚

 

Professional Experience 🧑‍🔬

Dr. Keun Hyung Park is currently the Head of SUNJIN Clinical Research Center, where he serves as Director and Principal Investigator (PI) since 2024. He is also a member of the expert committee for Cosinkorea and an advisory committee member of the Korea Bio Research Center. Previously, he was a lecturer in molecular biology at Kyung Hee University (2012-2013) and led the safety clinical team at IEC Korea (2014-2020). He held key roles in skin clinical consulting, including at THE K BEAUTY SCIENCE and OATC Skin Clinical Trial Center. 🧫🧴

 

Research Focus

Dr. Keun Hyung Park’s research primarily focuses on immunology and inflammation, particularly the molecular mechanisms underlying inflammatory responses and their modulation. His work explores the role of natural compounds in attenuating inflammation and promoting angiogenesis. Dr. Park investigates signaling pathways such as MAPK and NF-κB, contributing to our understanding of how these pathways influence immune cell behavior and tissue healing. Additionally, he examines the effects of various natural extracts on cellular processes, emphasizing their potential therapeutic applications in treating inflammatory diseases and enhancing wound healing. His research has significant implications for developing innovative treatments in biomedicine. 🧬🌿💉

 

Publication Top Notes

  • Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-κB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock (30 citations) – 2015 🐭
  • Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells (28 citations) – 2014 🌱
  • The stimulatory effects of Stewartia koreana extract on the proliferation and migration of fibroblasts and the wound healing activity of the extract in mice (20 citations) – 2014 🩹
  • Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs (33 citations) – 2013 🔬
  • Human lactoferrin suppresses TNF-α-induced intercellular adhesion molecule-1 expression via competition with NF-κB in endothelial cells (31 citations) – 2012 🧬

 

 

Naveen Khargekar | Public Health Award | Best Researcher Award

Published on by Academic Awards

Dr. Naveen Khargekar | Public Health Award | Best Researcher Award

Dr. Naveen Khargekar, ICMR-National Institute of Immunohaematology, India

Based on Dr. Naveen Khargekar’s extensive qualifications and achievements, he appears to be a strong candidate for the Research for Best Researcher Award. Here’s a detailed evaluation:

Publication profile

Education

Dr. Khargekar holds an MD in Community Medicine from Topiwala National Medical College, Mumbai, with a thesis focused on protein energy malnutrition in tribal areas. He further specialized in Preventive Oncology through a fellowship at Homi Bhabha National Institute, Tata Memorial Center. His UICC Technical Fellowship provided individual mentorship in cervical cancer, enhancing his expertise in cancer prevention and treatment.

Employments

Dr. Khargekar’s career includes significant roles such as Scientist-E at ICMR-National Institute of Immunohaematology, Assistant Professor in Preventive Oncology at Tata Memorial Center, and Consultant & Coordinator at Sri Shankara Cancer Hospital. His work demonstrates a strong commitment to cancer research and community oncology.

Teaching Activities

Dr. Khargekar has been involved in various educational initiatives, including workshops on tobacco control, preventive oncology, and sickle cell disease. His contributions to CME programs and residential workshops highlight his dedication to training and capacity building in the field of community and preventive medicine.

Workshops and Seminars

Dr. Khargekar’s participation in numerous workshops and seminars, including those on research methodology, good clinical practices, and systematic reviews, reflects his commitment to staying updated with the latest advancements and methodologies in research and public health.

Publication Top Notes

  1. Knowledge, attitude, and practice about cervical cancer and its screening among community healthcare workers of Varanasi district, Uttar Pradesh, India
    D Khanna, N Khargekar, A Budukh
    Journal of Family Medicine and Primary Care 8 (5), 1715-1719
    Cited by: 68 (2019) 🩺
  2. Compliance of cigarettes and other tobacco products act among tobacco vendors, educational institutions, and public places in Bengaluru City
    NC Khargekar, A Debnath, NR Khargekar, P Shetty, V Khargekar
    Indian Journal of Medical and Paediatric Oncology 39 (04), 463-466
    Cited by: 25 (2018) 🚭
  3. Immunization status of children under 5 years in a tribal area, Parol, Thane district
    NC Khargekar, VC Khargekar, PP Shingade
    National Journal of Community Medicine 6 (04), 522-527
    Cited by: 23 (2015) 💉
  4. Determinants of tobacco use and prevalence of oral precancerous lesions in cab drivers in Bengaluru City, India
    P Shetty, NC Khargekar, A Debnath, NR Khargekar, BK Srivastava
    International Journal of Preventive Medicine 8 (1), 100
    Cited by: 18 (2017) 🚬
  5. Role of social support in tobacco cessation
    N Khargekar
    International Journal of Community Medicine and Public Health 4 (11), 3942
    Cited by: 15 (2017) 💪
  6. Implementation of early detection services for cancer in India during COVID-19 pandemic
    D Khanna, NC Khargekar, AK Khanna
    Cancer Control 27 (1), 1073274820960471
    Cited by: 12 (2020) 🦠
  7. Cancer pattern in Varanasi district from Uttar Pradesh state of India, a foundation for cancer control based on the first report of the population-based cancer registry
    AM Budukh, S Pradhan, VB Singh, D Khanna, SS Bagal, PS Chakravarti
    Indian Journal of Cancer
    Cited by: 11 (2023) 🎗️
  8. A cross-sectional study to assess the protein energy malnutrition in children between one to five years of age in a tribal area Parol, Thane district, Maharashtra, India
    NC Khargekar, VC Khargekar, PP Shingade
    International Journal of Community Medical Public Health 3, 112-120
    Cited by: 8 (2016) 🍽️
  9. Cleft lip and palate-A psychology insight
    N Khargekar, N Khargekar, V Khargekar, S Rajan
    Sci Publ Group 5 (4), 37
    Cited by: 6 (2016) 👄
  10. Chronic Hepatitis B and Related Liver Diseases Are Associated with Reduced 25-Hydroxy-Vitamin D Levels: A Systematic Review and Meta-Analysis
    A Banerjee, S Athalye, N Khargekar, P Shingade, M Madkaikar
    Biomedicines 11 (1), 135
    Cited by: 5 (2023) 🦠
  11. Role of hydroxyurea therapy in the prevention of organ damage in sickle cell disease: a systematic review and meta-analysis
    N Khargekar, A Banerjee, S Athalye, N Mahajan, N Kargutkar, P Tapase
    Systematic Reviews 13 (1), 60
    Cited by: 4 (2024) 💊
  12. Exploring risk factors and transmission dynamics of Hepatitis B infection among Indian families: Implications and perspective
    S Athalye, N Khargekar, S Shinde, T Parmar, S Chavan, G Swamidurai
    Journal of Infection and Public Health 16 (7), 1109-1114
    Cited by: 4 (2023) 🦠
  13. A systematic review on hydroxyurea therapy for sickle cell disease in India
    A Pandey, H Kaur, S Borah, N Khargekar, VK Karra, T Adhikari, D Jain
    Indian Journal of Medical Research 156 (2), 299-311
    Cited by: 4 (2022) 💉
  14. A cross sectional assessment of the profile of risk factors of non-communicable diseases among health care staff of a tertiary cancer hospital
    N Khargekar, A Singh, T Shruti, S Pradhan
    Journal of Lifestyle Medicine 12 (2), 98
    Cited by: 4 (2022) 🏥
  15. Comparative study of clinical features and vaccination status in Omicron and non-Omicron infected patients during the third wave in Mumbai, India
    A Takke, M Zarekar, V Muthuraman, A Ashar, K Patil, A Badhavkar
    Journal of Family Medicine and Primary Care 11 (10), 6135-6142
    Cited by: 3 (2022) 🦠
  16. Is it possible to reduce cancer burden in India
    N Khargekar, V Khargekar, HG Srivatsa, N Khargekar
    J Med Sci Clin Res 5, 19837-44
    Cited by: 3 (2017) 🇮🇳
  17. Cancer Screening during COVID-19 Pandemic
    NC Khargekar, D Khanna
    Asia-Pacific Journal of Oncology Nursing 7 (4), 308-309
    Cited by: 2 (2020) 🦠
  18. Exploring factors influencing the perspective regarding HIV transmission and prevention among college students in India
    N Khargekar, A Takke, S Athalye, P Panale, N Rajamani, A Banerjee
    Journal of Family Medicine and Primary Care 13 (4), 1467-1472
    Cited by: 1 (2024) 🧬
  19. Impact of COVID-19 infection among Indian sickle cell disease patients
    N Khargekar, N Shinde, A Banerjee, M Madkaikar, A Nadkarni
    Indian Journal of Public Health 67 (1), 112-116
    Cited by: 1 (2023) 🦠
  20. Epidemiological study of adverse events following immunization in under 5 year children
    VS Pagar, SS Chavan, SP Patil, A Borde, AD Kinge, N Khargekar
    Journal of Family Medicine and Primary Care 10 (7), 2482-2487
    Cited by: 1 (2021) 💉

Conferences and Presentations

He has actively participated in national and international conferences, presenting papers on topics such as cancer screening compliance and hematological parameters in sickle cell anemia patients. His engagement in these forums demonstrates his active role in advancing medical knowledge and practices.

Achievements

Dr. Khargekar is a member of several institutional committees, including ethics and biosafety committees, which indicates his involvement in maintaining high standards of research ethics and safety.

Conclusion

Dr. Naveen Khargekar’s extensive education, diverse experience, active involvement in teaching and research, and significant contributions to peer-reviewed literature position him as a highly suitable candidate for the Research for Best Researcher Award. His work in preventive oncology and public health aligns well with the criteria for this prestigious award.

 

 

 

 

 

 

 

 

Masuma Mishu Mishu | Public Health Award | Best Researcher Award

Published on by Academic Awards

Dr. Masuma Mishu Mishu | Public Health Award | Best Researcher Award

Dr. Masuma Mishu Mishu, University College London, United Kingdom

Dr. Masuma Mishu: A Strong Contender for the Best Researcher Award

Publication profile

Scopus

Orcid

Education and Qualifications

Dr. Masuma Mishu earned her PhD in Epidemiology and Public Health (Dental Public Health group) from University College London in 2017, with research focused on the association of dental caries with height and weight in Bangladeshi children. She also holds a Master’s in Dental Public Health from the same institution, awarded with Merit, and a Bachelor of Dental Surgery (BDS) from Dhaka Dental College Hospital, where she graduated with first position.

Professional Career

Since July 2022, Dr. Mishu has been a Lecturer in Public Health at University College London and a Visiting Senior Research Fellow at the University of York’s Department of Health Science. Her roles involve teaching, curriculum development, and leading modules in Public Health. She also conducts public health research, leads two research projects as Principal Investigator (PI), and serves as a co-investigator on several others.

Awards and Recognition

Dr. Mishu has received notable recognition, including a nomination for the UCL Provost’s Award for Best Student’s Public Engagement Project in 2016 and being a finalist in the UCL-UCLU Three Minute Thesis Competition in 2015. She also received an award from UCL’s R=T team for her contributions to the Research=Teaching book as part of the UCL Connected Curriculum Project.

Conclusion

Dr. Masuma Mishu’s extensive academic background, significant contributions to public health research, and active involvement in teaching and curriculum development make her an exceptional candidate for the Best Researcher Award. Her achievements and ongoing research reflect a strong commitment to advancing the field of public health.

 

Publication Top Notes

  • “Developing a Consensus Statement to Target Oral Health Inequalities in People With Severe Mental Illness”
    Health Expectations, 2024-08
    DOI: 10.1111/hex.14163
  • “The Effect of Adult Smoking Behavior on Children’s Exposure to Secondhand Smoke. An Analysis Based on Salivary Cotinine Levels Among Children in Dhaka and Karachi”
    Nicotine and Tobacco Research, 2024-06-19
    DOI: 10.1093/ntr/ntae130
  • “Cross-culturally adapted psychological interventions for the treatment of depression and/or anxiety among young people: A scoping review”
    PLOS ONE, 2023-10-25
    DOI: 10.1371/journal.pone.0290653
  • “Children Learning About Secondhand Smoke (CLASS III): a protocol for a cluster randomised controlled trial of a school-based smoke-free intervention in Bangladesh and Pakistan”
    BMJ Open, 2023-07
    DOI: 10.1136/bmjopen-2022-068620
  • “The global impact of tobacco control policies on smokeless tobacco use: a systematic review”
    The Lancet Global Health, 2023-06
    DOI: 10.1016/S2214-109X(23)00205-X
  • “Co-creation of online learning in the Master of Public Health programme: perspectives from academics, learning designers and learning technologists”
    2023-04-19
    Source: University College London
  • “Letters to the Editor”
    Dental Update, 2023-03-01
    DOI: 10.12968/denu.2023.50.3.222
  • “The role of oral health‐related quality of life in the association between dental caries and height, weight and BMI among children in Bangladesh”
    Community Dentistry and Oral Epidemiology, 2022-12
    DOI: 10.1111/cdoe.12707
  • “Exploring the contextual factors, behaviour change techniques, barriers and facilitators of interventions to improve oral health in people with severe mental illness: A qualitative study”
    Frontiers in Psychiatry, 2022-10-11
    DOI: 10.3389/fpsyt.2022.971328
  • “A Qualitative Study Exploring the Barriers and Facilitators for Maintaining Oral Health and Using Dental Service in People with Severe Mental Illness: Perspectives from Service Users and Service Providers”
    International Journal of Environmental Research and Public Health, 2022-04
    DOI: 10.3390/ijerph19074344